TVARDI THERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $19.8M | $223.9M | $21.4M |
| Jun 2022 | $22.2M | $226.6M | $46.7M |
| Sep 2022 | $28.7M | $213.5M | $42.8M |
| Dec 2022 | $23.5M | $182.2M | $63.7M |
| Mar 2023 | $16.7M | $153.3M | $47.4M |
| Jun 2023 | $25.5M | $134.4M | $58.2M |
| Sep 2023 | $29.7M | $115.3M | $62.9M |
| Dec 2023 | $68.8M | $125.8M | $51.8M |
| Mar 2024 | $60.3M | $90.1M | $47.0M |
| Jun 2024 | $60.9M | $72.5M | $49.2M |
| Sep 2024 | $50.6M | $51.3M | $37.1M |
| Dec 2024 | $40.8M | $35.2M | $31.6M |
| Mar 2025 | $47.0M | $38.9M | $34.2M |
| Jun 2025 | $10.8M | $43.8M | $20.6M |
| Sep 2025 | $11.2M | $39.0M | $21.4M |
| Dec 2025 | $11.1M | $32.1M | $20.7M |
| Mar 2026 | $11.3M | $25.8M | $19.9M |
| Jun 2026 | $9.1M | $17.5M | $15.8M |